Annual ROE
-73.64%
-13.30%-22.04%
December 31, 2023
Summary
- As of February 8, 2025, SABS annual return on equity is -73.64%, with the most recent change of -13.30% (-22.04%) on December 31, 2023.
- During the last 3 years, SABS annual ROE has fallen by -125.21% (-242.80%).
- SABS annual ROE is now -118.89% below its all-time high of 389.76%, reached on December 31, 2019.
Performance
SABS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-94.37%
-0.33%-0.35%
September 30, 2024
Summary
- As of February 8, 2025, SABS quarterly return on equity is -94.37%, with the most recent change of -0.33% (-0.35%) on September 30, 2024.
- Over the past year, SABS quarterly ROE has increased by +25.99% (+21.59%).
- SABS quarterly ROE is now -2714.13% below its all-time high of 3.61%, reached on March 31, 2021.
Performance
SABS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SABS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.0% | +21.6% |
| 3 y3 years | -242.8% | -55.3% |
| 5 y5 years | -118.9% | -55.3% |
SABS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.6% | at low | -237.0% | +34.8% |
| 5 y | 5-year | -118.9% | at low | -2714.1% | +34.8% |
| alltime | all time | -118.9% | at low | -2714.1% | +34.8% |
SAB Biotherapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -94.37%(+0.4%) |
| Jun 2024 | - | -94.04%(-14.4%) |
| Mar 2024 | - | -109.90%(-24.0%) |
| Dec 2023 | -73.64%(+22.0%) | -144.66%(+20.2%) |
| Sep 2023 | - | -120.36%(+9.1%) |
| Jun 2023 | - | -110.34%(+34.0%) |
| Mar 2023 | - | -82.33%(+56.9%) |
| Dec 2022 | -60.34% | -52.46%(-13.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -60.77%(+75.2%) |
| Jun 2022 | - | -34.68%(+11.0%) |
| Mar 2022 | - | -31.24%(+11.6%) |
| Dec 2021 | -44.47%(-186.2%) | -28.00%(+207.4%) |
| Sep 2021 | - | -9.11%(+129.5%) |
| Jun 2021 | - | -3.97%(-210.0%) |
| Mar 2021 | - | 3.61% |
| Dec 2020 | 51.57%(-86.8%) | - |
| Dec 2019 | 389.76% | - |
FAQ
- What is SAB Biotherapeutics annual return on equity?
- What is the all time high annual ROE for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual ROE year-on-year change?
- What is SAB Biotherapeutics quarterly return on equity?
- What is the all time high quarterly ROE for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly ROE year-on-year change?
What is SAB Biotherapeutics annual return on equity?
The current annual ROE of SABS is -73.64%
What is the all time high annual ROE for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual return on equity is 389.76%
What is SAB Biotherapeutics annual ROE year-on-year change?
Over the past year, SABS annual return on equity has changed by -13.30% (-22.04%)
What is SAB Biotherapeutics quarterly return on equity?
The current quarterly ROE of SABS is -94.37%
What is the all time high quarterly ROE for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly return on equity is 3.61%
What is SAB Biotherapeutics quarterly ROE year-on-year change?
Over the past year, SABS quarterly return on equity has changed by +25.99% (+21.59%)